Lido Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.64M | Sell |
87,746
-1,555
| -2% | -$149K | 0.02% | 369 |
|
|
2025
Q4 | $8.57M | Sell |
89,301
-8,141
| -8% | -$791K | 0.03% | 349 |
|
|
2025
Q3 | $9.32M | Buy |
97,442
+51,432
| +112% | +$4.73M | 0.03% | 319 |
|
|
2025
Q2 | $4.04M | Sell |
46,010
-5,288
| -10% | -$448K | 0.02% | 422 |
|
|
2025
Q1 | $4.65M | Buy |
51,298
+6,667
| +15% | +$597K | 0.02% | 356 |
|
|
2024
Q4 | $3.6M | Buy |
44,631
+79
| +0.2% | +$6.84K | 0.02% | 394 |
|
|
2024
Q3 | $4.01M | Sell |
44,552
-686
| -2% | -$57.7K | 0.02% | 343 |
|
|
2024
Q2 | $3.59M | Sell |
45,238
-83,855
| -65% | -$6.87M | 0.02% | 335 |
|
|
2024
Q1 | $11.3M | Buy |
129,093
+17,615
| +16% | +$1.5M | 0.07% | 156 |
|
|
2023
Q4 | $9.25M | Buy |
111,478
+74,144
| +199% | +$5.65M | 0.06% | 173 |
|
|
2023
Q3 | $2.93M | Sell |
37,334
-31,756
| -46% | -$2.66M | 0.02% | 315 |
|
|
2023
Q2 | $6.09M | Buy |
69,090
+10,104
| +17% | +$870K | 0.04% | 194 |
|
|
2023
Q1 | $698K | Buy |
58,986
+45,511
| +338% | +$3.71M | 0.01% | 567 |
|
|
2022
Q4 | $1.05M | Sell |
13,475
-2,055
| -13% | -$167K | 0.01% | 405 |
|
|
2022
Q3 | $1.25M | Sell |
15,530
-991
| -6% | -$89.1K | 0.02% | 325 |
|
|
2022
Q2 | $1.48M | Sell |
16,521
-980
| -6% | -$99.3K | 0.02% | 270 |
|
|
2022
Q1 | $1.94M | Buy |
17,501
+271
| +2% | +$28.6K | 0.02% | 267 |
|
|
2021
Q4 | $1.78M | Sell |
17,230
-2,684
| -13% | -$311K | 0.02% | 301 |
|
|
2021
Q3 | $2.5M | Buy |
19,914
+8,081
| +68% | +$1.05M | 0.03% | 239 |
|
|
2021
Q2 | $1.48M | Buy |
11,833
+60
| +0.5% | +$7.53K | 0.02% | 307 |
|
|
2021
Q1 | $1.4M | Sell |
11,773
-3,726
| -24% | -$437K | 0.02% | 281 |
|
|
2020
Q4 | $1.82M | Buy |
15,499
+5,582
| +56% | +$614K | 0.04% | 224 |
|
|
2020
Q3 | $1.04M | Sell |
9,917
-8,460
| -46% | -$850K | 0.03% | 250 |
|
|
2020
Q2 | $1.7M | Buy |
18,377
+1,629
| +10% | +$156K | 0.05% | 174 |
|
|
2020
Q1 | $1.52M | Sell |
16,748
-1,233
| -7% | -$131K | 0.06% | 170 |
|
|
2019
Q4 | $2.05M | Buy |
17,981
+5,586
| +45% | +$613K | 0.08% | 138 |
|
|
2019
Q3 | $1.35M | Buy |
12,395
+9,718
| +363% | +$1.01M | 0.07% | 168 |
|
|
2019
Q2 | $260K | Sell |
2,677
-1,213
| -31% | -$111K | 0.01% | 453 |
|
|
2019
Q1 | $356K | Sell |
3,890
-47
| -1% | -$4.21K | 0.02% | 351 |
|
|
2018
Q4 | $359K | Sell |
3,937
-78
| -2% | -$7.29K | 0.04% | 275 |
|
|
2018
Q3 | $396K | Buy |
4,015
+1,143
| +40% | +$106K | 0.04% | 284 |
|
|
2018
Q2 | $245K | Sell |
2,872
-62
| -2% | -$5.18K | 0.03% | 350 |
|
|
2018
Q1 | $235K | Sell |
2,934
-463
| -14% | -$38.2K | 0.03% | 322 |
|
|
2017
Q4 | $274K | Buy |
3,397
+797
| +31% | +$63.8K | 0.04% | 242 |
|
|
2017
Q3 | $209K | Buy |
+2,600
| New | +$216K | 0.03% | 258 |
|
Other funds holding MDT
VCM
VPM
Lido Advisors's MDT Position: Q1 2026 in Review
Lido Advisors reduced its Medtronic (MDT) stake by 1.7% in Q1 2026, selling an estimated $149K and leaving 87,746 shares worth $7.64M. The position accounts for 0.02% of the portfolio, ranked #369.
Lido Advisors first reported a position in MDT in Q3 2017 and has held it in 35 quarters since. The position peaked at $11.3M in Q1 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Lido Advisors held 87,746 shares of Medtronic worth $7.64M as of Q1 2026.
- Lido Advisors sold 1,555 Medtronic shares in Q1 2026, an estimated $149K.
- Medtronic made up 0.02% of Lido Advisors's portfolio in Q1 2026, its #369 holding.
- Lido Advisors first reported a position in Medtronic in Q3 2017 and has held it in 35 quarters since.
- Lido Advisors's Medtronic position peaked at $11.3M in Q1 2024.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.